scispace - formally typeset
L

Luigia Morelli

Researcher at University of Genoa

Publications -  18
Citations -  3915

Luigia Morelli is an academic researcher from University of Genoa. The author has contributed to research in topics: Receptor & Natural killer cell. The author has an hindex of 15, co-authored 18 publications receiving 3793 citations. Previous affiliations of Luigia Morelli include University of Brescia.

Papers
More filters
Journal ArticleDOI

Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

TL;DR: NKp30 is identified, a novel 30-kD triggering receptor selectively expressed by all resting and activated human natural killer (NK) cells, and is associated with CD3ζ chains that become tyrosine phosphorylated upon sodium pervanadate treatment of NK cells.
Journal ArticleDOI

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

TL;DR: The first characterization of the molecular structure of a NK-specific receptor involved in the mechanism of NK cell activation during natural cytotoxicity is reported, involving a novel member of the immunoglobulin (Ig) superfamily.
Journal ArticleDOI

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

TL;DR: Support to the concept that p58 molecules represent a NK receptor delivering a negative signal was provided by experiments in which the entire anti-p58 mAbs could inhibit the lysis of unprotected Fc gamma R- target cells, thus mimicking the inhibitory effect of MHC class I molecules.
Journal ArticleDOI

p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation

TL;DR: Both the unique cellular distribution and functional capability of p46 molecules suggest a possible role in the mechanisms of non-major histocompatibility complex–restricted cytolysis mediated by human NK cells.
Journal ArticleDOI

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

TL;DR: It is shown that EB6 molecules may also act as receptors mediating NK cell triggering, and clones expressing the activatory p50/EB6 molecules consistently coexpressed inhibitory receptors for other HLA class I alleles.